AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gleznor M 30mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Costa Rich Pharmaceuticals

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Gleznor M 30mg/500mg Tablet

Diabetac Duo 30mg/500mg tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This dual-action formula helps regulate blood glucose. Diabetac Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (e.g., sugary foods or juice) is essential for hypoglycemia management. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Gleznor M 30mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Gleznor M 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gleznor M 30mg/500mg Tablet whole; do not break, crush, or chew it. Administer this medicine with food.

Common Side effects of Gleznor M 30mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gleznor M 30mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gleznor M 30mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Gleznor M 30mg/500mg Tablet works:

Gliclazide and metformin are combined in Gleznor M 30mg/500mg tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gleznor M 30mg/500mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gleznor M 30mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gleznor M 30mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gleznor M 30mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult your physician. Gleznor M 30mg/500mg Tablets are contraindicated in patients with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Gleznor M 30mg/500mg tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Gleznor M 30mg/500mg Tablet :

Should you forget a Gleznor M 30mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gleznor M 30mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gleznor M 30mg/500mg Tablet

Gleznor M 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This treatment improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 DM.
Gleznor M 30mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Yes, Gleznor M 30mg/500mg Tablets can lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medication is taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Gleznor M 30mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Gleznor M 30mg/500mg Tablets and seek immediate medical attention.
Prolonged Gleznor M 30mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Gleznor M 30mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gleznor M 30mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gleznor M 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gleznor M 30mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Yes, Gleznor M 30mg/500mg Tablets can cause low blood sugar (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This is more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Gleznor M 30mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gleznor M 30mg/500mg Tablets and seek immediate medical attention.
Prolonged Gleznor M 30mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gleznor M 30mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Use is also contraindicated in patients with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Gleznor M 30mg/500mg tablets is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gleznor M 30mg/500mg Tabl...
57
MRP 69
17% off